Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Scientific Reports|February 2, 2023
Relationship between brain metastasis and thyroid transcription factor 1Engin Kut, Serkan MenekşeCureus|March 7, 2023
Retrospective Evaluation of Fulvestrant Efficacy and Clinical Results in Patients Using FulvestrantEngin Kut, Serkan MenekseScientific Reports|January 16, 2024
Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancerEngin Kut, Serkan MenekseCureus|February 15, 2023
Prognostic Relationship Between the ABO Blood Groups and Metastatic Gastric CancerElif Tugba Tuncel, Engin KutSao Paulo Medical Journal = Revista Paulista De Medicina|January 18, 2018
Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis: case reportYasemin Benderli Cihan, Engin Kut, Ali KoçAsia-Pacific Journal of Oncology Nursing|January 11, 2021
Mediating Role of Social Support in Resilience and Quality of Life in Patients with Breast Cancer: Structural Equation Model AnalysisGülden Küçükakça Çelik, Hatice Çakır, Engin KutCureus|March 27, 2023
Effect of Postoperative Adjuvant Radiotherapy on Quality of Life, Anxiety, and Depression in Adult Female Breast Cancer PatientsMurtaza Parvizi, Engin Kut, Murat Akyol, et al.Asian Pacific Journal of Cancer Prevention : APJCP|August 30, 2014
Efficacy and safety of docetaxel or epirubicin, combined with cisplatin and fluorouracil (DCF and ECF), regimens as first line chemotherapy for advanced gastric cancer: a retrospective analysis from TurkeyFatih Teker, Bahiddin Yilmaz, Yasemin Kemal, et al.Future Oncology (London, England)|February 26, 2021
Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastasesZeynep Oruç, M Ali Kaplan, Mustafa Karaağaç, et al.BMC Cancer|August 5, 2025
Evaluation of pre-treatment F-18 FDG PET/CT according to Mandard classification in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapyFeray Aras, Murtaza Parvizi, Olcay Ak Nalbant, et al.Pageof 4